Jinzhou Medical University Reports Findings in Personalized Medicine (Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant mel anoma)
Jinzhou Medical University Reports Findings in Personalized Medicine (Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant mel anoma)
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of areport. According to news reporting or iginating from Liaoning, People’s Republic of China, by NewsRxcorrespondents, r esearch stated, “Cutaneous malignant melanoma is a very aggressive and metastati cform of skin cancer, typically linked with poor outcomes. Advances in genomic analysis have underscoredthe crucial role of T cells in tumor immunity.”
Key words
Liaoning/People’s Republic of China/As ia/Biomarkers/Cancer/Cutaneous Melanoma/Cyborgs/Diagnostics and Screening/Drugs and Therapies/Emerging Technologies/Genetics/Health and Medicine/Immun otherapy/Machine Learning/Melanoma/Oncology/Personalized Medicine/Personali zed Therapy/Prognostic Markers/Risk and Prevention
NETL
NSTL